Targeted PSMA-PET is now widely used in imaging diagnostics for PCa, including early diagnosis, staging, advanced metastasis assessment, and detecting biochemical recurrence post-prostatectomy (23). This evidence concerns the gene FOLH1 and posterior cortical atrophy.